Much has changed in how we understand and treat eating disorders. Some significant aspects have remained consistent or ...
Idorsia’s dual orexin receptor antagonist, the first and only drug of its kind approved in Europe for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback